First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - AKRO PHARMACEUTICAL COMPANY LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: AKRO PHARMACEUTICAL COMPANY LIMITED, ABACUS HOUSE, 68A NORTH STREET, ROMFORD, ESSEX, RM1 1DA. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 May 2023. The company was incorporated on 28 September 1998.

The accounts next due date is 28 February 2025. There is 1 mortgage, which is unsatisfied

The above was based on public record information as at 13 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 03639498
Date Incorporated: 28 September 1998
Date Latest Accounts: 31 May 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 03639498
Annual Return: 28 September 2015
Registered Office: ABACUS HOUSE, 68A NORTH STREET, ROMFORD, ESSEX, RM1 1DA
SIC Code and Operations: 46460
SECURED CREDITORS
Number of Mortgages 1
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

AKRO PHARMACEUTICAL COMPANY LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 23 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
SC135720 AKRO PLANT LIMITED Active
13333742 AKRO PROPERTIES LIMITED Active
13392297 AKRO PROPERTY MANAGEMENT LTD Active
10464462 AKRO RAIL LIMITED Active - Proposal to Strike off
14630202 AKRO SOLUTIONS LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd